Cogent Biosciences Earnings
NASDAQ: COGTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Fri, Nov 6, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.57
Cogent Biosciences earnings summary
Cogent Biosciences is scheduled to report Sep/2026 earnings on Nov 6, 2026, with analysts expecting EPS of $-0.57. In its most recent report on Aug 10, 2026 (Q2 2026), COGT posted EPS of $-0.52. Across the last 16 reports, COGT shares moved an average of 13.3% (in either direction) in the first trading session after results, rising 8 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
COGT earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 10, 2026 | — | $-0.52 | — | -3.2% |
| May 5, 2026 | — | $-0.53 | — | -5.9% |
| Feb 17, 2026 | — | $-0.61 | — | +4.0% |
| Nov 7, 2025 | — | $-0.50 | — | +126.3% |
| Aug 5, 2025 | — | $-0.53 | — | +8.5% |
| May 6, 2025 | — | $-0.52 | — | +1.5% |
| Feb 25, 2025 | — | $-0.50 | — | -6.9% |
| Nov 12, 2024 | — | $-0.52 | — | +2.6% |
| Aug 6, 2024 | — | $-0.43 | — | +10.3% |
| May 7, 2024 | — | $-0.49 | — | -1.6% |
| Feb 26, 2024 | — | $-0.16 | — | -8.9% |
| Nov 7, 2023 | — | $-0.64 | — | +15.7% |
| Aug 8, 2023 | — | $-0.59 | — | -2.7% |
| May 9, 2023 | — | $-0.55 | — | -2.8% |
| Mar 14, 2023 | — | $0.16 | — | -11.8% |
| Nov 14, 2022 | — | $-0.50 | — | +0.4% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.